Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673916 | SCV000799172 | uncertain significance | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2018-04-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000673916 | SCV003231845 | pathogenic | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2022-08-21 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ACADM protein in which other variant(s) (p.Asp181Gly) have been determined to be pathogenic (PMID: 23430840). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 557739). This variant has not been reported in the literature in individuals affected with ACADM-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.536_568del, results in the deletion of 11 amino acid(s) of the ACADM protein (p.Lys179_Lys189del), but otherwise preserves the integrity of the reading frame. |
Baylor Genetics | RCV000673916 | SCV004217355 | likely pathogenic | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2023-02-22 | criteria provided, single submitter | clinical testing |